Literature DB >> 629072

[The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) (author's transl)].

O A Beck, J Vogt, H Hochrein.   

Abstract

Hemodynamic changes after single intravenous injection of antiarrhythmic doses of propafenone (70 mg) and lidocaine (100 mg) were measured comparatively in 11 patients with acute myocardial infarction, stable cardiac rhythm and without evidence of manifest left heart failure. The effects of propafenone were characterized by a significant decrease of cardiac index by 6% and an increase in left and right ventricular filling pressures by 15% and 23%. Mean arterial pressure was significantly lowered (8%) and left ventricular stroke work index decreased by an average of 11%. Mean pulmonary artery pressure significantly increased by 7%. A fall in systemic vascular resistance by 7% was not statistically significant. Intravenous administration of propafenone at a dose of 70 mg thus caused a transitory decrease in ventricular function and acute vasodilation with a fall in systemic blood pressure. The intravenous administration of lidocaine did not result in significant changes of cardiac index or left and right ventricular filling pressures. Mean pulmonary artery pressure, systemic blood pressure and vascular resistance increased significantly.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629072

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  3 in total

1.  Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.

Authors:  B Silke; M A Frais; S P Verma; G W Reynolds; M Hafizullah; P A Kalra; N C Jackson; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

2.  Long term inotropic effects of flecainide and propafenone.

Authors:  E Henze; J Roth; W Haerer; W E Adam; M Stauch
Journal:  Eur J Nucl Med       Date:  1988

3.  Propafenone for the treatment of severe ventricular arrhythmias.

Authors:  S W Rabkin; C E Rotem; K Boroomand-Rashti; B Bar-Shlomo
Journal:  Can Med Assoc J       Date:  1984-09-15       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.